Prevalent Cases of Dyslipidemia in Nine Major Markets to Reach 522 Million Cases in 2022, Expects GlobalData

01 Mar 2013 • by Natalie Aster

Lifestyle factors, including a sedentary lifestyle and high caloric and alcohol intake are contributing to an increase in prevalent cases of dyslipidemia across India.

The report "EpiCast Report: Dyslipidemia Epidemiology Forecast to 2022" by GlobalData, forecasts the number of dyslipidemia sufferers across the South Asian nation to climb from 192.7 million in 2012 to 245 million by the end of 2022 – a growth of 27% in just 10 years. GlobalData attributes this jump in prevalent cases primarily to the expected continuation of healthy population growth.

Report Details:

EpiCast Report: Dyslipidemia Epidemiology Forecast to 2022
Published: December, 2012
Pages: 44
Price: US$ 6,995.00

The nation with the second largest increase across the nine countries studied in the report, China, is predicted to increase by a comparatively modest 15% during the same period – from 84.7 million prevalent cases in 2012 to 97.1 million a decade on.

GlobalData’s epidemiologists forecast that the prevalent cases of dyslipidemia in the nine major markets (the US, China, Japan, India and the five top European markets) will increase from 444 million cases in 2012 to 522 million cases in 2022 at an Annual Growth Rate (AGR) of 1.76%.

More information can be found in the report “EpiCast Report: Dyslipidemia Epidemiology Forecast to 2022” by GlobalData.

To order the report or ask for sample pages contact


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970